
In a study of 40,292 participants, individuals in the top 10% for prostate cancer risk, as determined by PRS, underwent MRI and biopsy, revealing prostate cancer in 40% of cases. Of these, over half had intermediate or higher-risk cancers, which would have been missed with traditional screening methods based on PSA or MRI alone. The approach highlights the potential for better detection of clinically significant prostate cancer.
Like
Save
Share